1-9 of 9
Atul Mehta, MD
Close
Sort by
Journal Articles

A Global Delphi Consensus Initiative for Early Diagnosis of Gaucher Disease: Barriers, Their Resolution and the Impact on Patients

David J Kuter, MD DPhil, Sam Salek, PhD, Atul Mehta, MD
Journal: Blood
Blood (2016) 128 (22): 4885.
https://doi.org/10.1182/blood.V128.22.4885.4885
Published: 2016
Journal Articles

Key Presenting Signs and Patient Co-Variables in Early Diagnosis of Type 3 Gaucher Disease: A Global Delphi Consensus Initiative

David J Kuter, MD DPhil, Sam Salek, PhD, Atul Mehta, MD
Journal: Blood
Blood (2016) 128 (22): 4886.
https://doi.org/10.1182/blood.V128.22.4886.4886
Published: 2016
Journal Articles

Physical and Psychological Factors Influencing Fatigue and Quality of Life in Multiple Myeloma Survivors: Preliminary Results from the Mascot Lifestyle Study

Malgorzata Heinrich, PhD, Joanne Land, BSc, Orla McCourt, MSc, Stephanie Philpott, MSc, Bruce Paton, PhD, Rebecca J Beeken, PhD, Lee Smith, PhD, Dunnya De-Silva, MBBS, Ali Rismani, MBBS, Shirley D'Sa, Anastasia Chew, MBBS, MRCP, FRCPATH, Atul Mehta, MD, Abigail Fisher, PhD, Allan Hackshaw, PhD, Kwee L Yong
Journal: Blood
Blood (2016) 128 (22): 4776.
https://doi.org/10.1182/blood.V128.22.4776.4776
Published: 2016
Journal Articles

A Global Delphi Consensus Initiative for Early Diagnosis of Gaucher Disease: Key Presenting Signs and Patient Co-Variables in Type 1 Disease

David J Kuter, MD DPhil, Sam Salek, PhD, Atul Mehta, MD
Journal: Blood
Blood (2016) 128 (22): 3676.
https://doi.org/10.1182/blood.V128.22.3676.3676
Published: 2016
Journal Articles

Vial Sharing of Bortezomib Is Logistically Feasible and Significantly Reduces Drug Wastage and the Cost of Myeloma Treatment

Simon Cheesman, Aoife Shields, Raakhee Shah, Nisha Thakrar, Jeff Bradley, Tom Marler-Hausen, Shirley D'Sa, Charalampia Kyriakou, Atul Mehta, MD, Rakesh Popat, Neil Rabin, Ali Rismani, MBBS, Kwee L Yong, Ashu Wechalakar
Journal: Blood
Blood (2016) 128 (22): 5956.
https://doi.org/10.1182/blood.V128.22.5956.5956
Published: 2016
Journal Articles

Duration of Therapy Is Independently Associated with Improved Progression Free and Overall Survival Following First Line Therapy for Non-Transplant Eligible Patients with Multiple Myeloma: Retrospective Analysis from a Single Centre

Dunnya De-Silva, MBBS, Adam Bloomfield, Nicholas Counsell, Simon Cheesman, BPharm, Ali Rismani, MBBS, Neil Rabin, Shirley D'Sa, Charalampia Kyriakou, Jayne Galinsky, Sarah Richard, Rakesh Popat, Atul Mehta, MD, Kwee L Yong
Journal: Blood
Blood (2016) 128 (22): 5684.
https://doi.org/10.1182/blood.V128.22.5684.5684
Published: 2016
Journal Articles

Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study,

David J. Kuter, MD, DPhil, Atul Mehta, MD, Carla Hollak, MD, PhD, Pilar Giraldo, MD, PhD, Derralynn Hughes, MRCP, MRCPath, DPhil, MA, Nadia Belmatoug, MD, Monika Brand, Audrey Muller, Berthold Schaaf, Ruben Giorgino, Ari Zimran, MD
Journal: Blood
Blood (2011) 118 (21): 3207.
https://doi.org/10.1182/blood.V118.21.3207.3207
Published: 2011
Journal Articles

Hepcidin Dysregulation in Patients with Type 1 Gaucher’s Disease.

Derralynn A. Hughes, MA DPhil MRCP, Anna Li, BSc, Satish Keshav, DPhil FRCP, Atul Mehta, MD FRCP FRCPath
Journal: Blood
Blood (2004) 104 (11): 3824.
https://doi.org/10.1182/blood.V104.11.3824.3824
Published: 2004
Journal Articles

Conserved Amino Acid Sequences Occur in a Limited Group of CLL Patients with Predominantly Mutated IGH Rearrangements.

Veronique M. Duke, BSc PhD, Birithini Yogashangari, BSc, Domenica Gandini, MD PhD, Paul D. Sherrington, MD PhD, Atul Mehta, MD, A. Victor Hoffbrand, Letizia Foroni, MD PhD
Journal: Blood
Blood (2004) 104 (11): 2000.
https://doi.org/10.1182/blood.V104.11.2000.2000
Published: 2004